Q32 Bio to join Russell 3000 Index
PremiumThe FlyQ32 Bio to join Russell 3000 Index
3M ago
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
Premium
The Fly
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
4M ago
Guggenheim starts Q32 Bio with a Buy, Street-high $100 price target
Premium
The Fly
Guggenheim starts Q32 Bio with a Buy, Street-high $100 price target
4M ago
Q32 Bio reports Q1 EPS ($6.33), consensus ($2.32)
PremiumThe FlyQ32 Bio reports Q1 EPS ($6.33), consensus ($2.32)
5M ago
Q32 Bio files to sell 1.68M shares of common stock for holders
Premium
The Fly
Q32 Bio files to sell 1.68M shares of common stock for holders
6M ago
Oppenheimer starts Q32 Bio with Outperform, sees 150% potential upside
Premium
The Fly
Oppenheimer starts Q32 Bio with Outperform, sees 150% potential upside
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100